NCT06965127 Implant for Walking After Incomplete SCI
| NCT ID | NCT06965127 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Louis Stokes VA Medical Center |
| Condition | Spinal Cord Injury (SCI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 5 participants |
| Start Date | 2025-08-27 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 5 participants in total. It began in 2025-08-27 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a device study that will evaluate the effect of an implanted stimulator on improving walking in people with incomplete spinal cord injury. There are two phases in the study: 1) Screening - this phase determines if the individual is a good candidate to receive an implanted system, 2) Implantation, controller development, and evaluation - this phase includes implanting the device and setting the individual up for system use, creating controllers for walking, and evaluating the effect of the device over a couple years.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18-75 * Non-ventilator dependent paralysis resulting from injuries such as: cervical/thoracic spinal cord injuries affecting the trunk and/or lower limbs * Impairment classification of AIS B, C, or D (preservation of sensation and/or some motor function) with weakness in trunk and/or lower extremity muscles * Unable to walk faster than 0.8m/s during a 10m walk test * Gait deviation such as reduced peak hip, knee, and/or ankle range of motion during stance or swing phases due to motor impairment * Time post injury greater than six months * Innervated and excitable lower extremity and trunk musculature * Adequate social support and stability * Willingness to comply with follow-up procedures * Appropriate body habitus (height and weight within acceptable limits as determined by study physician) * Neurologically stable as determined by a physician Exclusion Criteria: * Significant fracture risk or history of spontaneous fractures * History of heterotopic ossification at the hip, knee, or ankle * Non-English speaking * Insufficient upper extremity function to use an assistive device (e.g. walker or cane) * Females who are pregnant * Current pressure injury that would be exacerbated by study activities * Uncontrolled spasticity that would interfere with study activities * Significant range of motion limitations that would compromise study activities * History of vestibular dysfunction, balance problems, or spontaneous falls * Disorder or condition that require MRI monitoring * Acute and/or untreated orthopedic issues that would prevent weight bearing or exercising implanted muscles such as a dislocation or fracture * Acute and/or chronic medical problems left untreated or not controlled that would increase risk by using stimulation such as cardiac abnormalities, immunological/pulmonary/renal/circulatory compromise * Uncontrolled diabetes or hypertension * Presence of a demand pacemaker, cardiac defibrillator, or neuroprosthesis system with components in the legs * Any other medical or psychological condition that would be a contraindication Implant eligibility criteria • In addition to all of the above, the participant must be able to fully support their body weight in standing with an assistive device prior to implantation.
Contact & Investigator
Nathan Makowski, PhD
PRINCIPAL INVESTIGATOR
MetroHealth System, Ohio
Frequently Asked Questions
Who can join the NCT06965127 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Spinal Cord Injury (SCI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06965127 currently recruiting?
Yes, NCT06965127 is actively recruiting participants. Contact the research team at lisa.lombardo2@va.gov for enrollment information.
Where is the NCT06965127 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT06965127 clinical trial?
NCT06965127 is sponsored by Louis Stokes VA Medical Center. The principal investigator is Nathan Makowski, PhD at MetroHealth System, Ohio. The trial plans to enroll 5 participants.